Tesla, Twilio, Novo Nordisk, Texas Instruments, Boeing, Amex, Verizon: Biggest Movers
Customers Bancorp, Twilio, Dana And Other Big Stocks Moving Higher On Friday
Novo Nordisk Up Over 8%, On Track for Largest Percent Increase Since March 2024 -- Data Talk
Novo-Nordisk A/S once surged over 10% due to impressive trial data for the new weight-loss drug Amycretin.
① Novo-Nordisk A/S announced the latest trial results of its new weight loss drug Amycretin, which can help patients lose an average of 22%, better than the company's currently sold Semaglutide; ② The Amycretin drug may help Novo-Nordisk A/S compete with its major rival Eli Lilly and Co.
Sector Update: Health Care Stocks Decline Premarket Friday
Sector Update: Health Care
